Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2023 and 2024.
Financials
Financial year 2024
WALPHARMA from Arlon, company number BE0442452731, closed financial year 2024 with a result of € -27,936 after tax. For that financial year WALPHARMA recorded a gross margin of € 39,736 and equity of € 98,407. Compared with financial year 2023, the result moved from € -26,815 to € -27,936. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2025.
€ 98,407
▼ 22% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -27,936
▼ 4 % more loss than in 2023
Profit after tax over the fiscal year.
€ 49,208
▼ 8% vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 79,815.
People and assets in 2024
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 46,759
▲ 1% vs 2023
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,468
▼ 65% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 11,224
▼ 54% vs 2023
Loans from banks and other lenders, long and short.
€ 22,656
▼ 39% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 4,326
▼ 83% vs 2023
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € -5,703 | € 49,361 | € 43,206 | € 39,736 | ▼ 8% |
| Profit after taxes | € -75,529 | € -18,971 | € -26,815 | € -27,936 | ▼ € 1,121 |
| Equity | € 172,129 | € 153,158 | € 126,343 | € 98,407 | ▼ 22% |
| Total debts | € 118,864 | € 135,109 | € 150,344 | € 104,346 | ▼ 31% |
| Cash | € 33,888 | € 48,528 | € 53,691 | € 49,208 | ▼ 8% |
| Retained profit | € 153,537 | € 134,566 | € 107,751 | € 79,815 | ▼ 26% |
| Bank debt | € 50,643 | € 37,760 | € 24,650 | € 11,224 | ▼ 54% |
| Balance sheet total | € 290,993 | € 288,268 | € 276,687 | € 202,753 | ▼ 27% |
Key figures of WALPHARMA, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to WALPHARMA?
What happened at WALPHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: loss of € 27,936. filed late Source: NBB ↗
- New establishment in Arlon. KBO
- Start of the company according to the CBE. KBO
In short
From € 75,529 loss in 2021 to € 27,936 loss in 2024.
Paid € 1,712 in corporate taxes since 2021.
Management
Behind WALPHARMA is Bernard Waltzing.
Directors
According to the 2024 annual accounts
Bernard Waltzing
Director
Establishments
Establishment units
Physical locations of this company
Avenue de la Gare 13
6700 Arlon
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0442.452.731
- VAT number
- BE 0442.452.731
- Registered office
- Avenue de la Gare 13, 6700 Arlon
- Names & denominations
- WALPHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 December 1990
- Peppol
- Active · Active since 30 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers
Detailhandel in cosmetica en toiletartikelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels